$DRTS

$12.89 -$0.27 (2.05%) Close

$DRTS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 88.0M shares outstanding

Who owns DRTS?

By type of holder

Institutions 8.9% Insiders 0.0% Everyone else 91.1%

Concentration Top 10 holders own 22.9%

Oramed Pharmaceuticals Inc. 16.0% · Gem Investment Advisors, LLC 1.6%

Institutional ownership

8.9%

+4.3 pts vs last qtr

Institutional holders

+19 vs last qtr

Net shares bought

+3.8M

by institutions in Q2 2026

New / sold out

26 / 7

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Gem Investment Advisors, LLC +1.3M
Boothbay Fund Management, LLC NEW +773.5K

Biggest sellers in Q2 2026

Millennium Management LLC SOLD OUT −46.4K
Renaissance Technologies LLC SOLD OUT −40.5K

Who is planning to sell?

Notices of proposed sale, last 12 months

$3.29M

16 notices from 3 people

Shares covered

445.8K

0.51% of the company

Arranged in advance

91%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Levy Raphi Officer $1.87M
Gat Amnon Officer 10b5-1 $1.35M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2019–FY2025

+138.3%

+15.57% a year

Each share's claim on the business

−58.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $37.2M

over 7 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years4% 1–3 years26% Under 1 year70%

Quarterly turnover

52.1%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting DRTS on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
GI Gem Investment Advisors, LLC	1.4M	1.63%	+1.3M (+1161.2%)	Q4 '25	11.1%
Shares held by quarter Peak holding1.4M (Q2'26) Change over 8 quarters+1.4M Share of the company1.630% Gem Investment Advisors, LLC's full portfolio →
HA HighTower Advisors, LLC	875.0K	0.99%	Unchanged	2023	0.0%
Shares held by quarter Peak holding875.0K (Q1'26) Change over 8 quarters+644.3K Share of the company0.990% HighTower Advisors, LLC's full portfolio →

Gem Investment Advisors, LLC

1.4M

% of company

1.63%

Change vs last qtr

+1.3M (+1161.2%)

Held since

Q4 '25

HighTower Advisors, LLC

875.0K

% of company

0.99%

Change vs last qtr

Unchanged

Held since

2023

28 more super investors behind a free account

See every manager holding Alpha Tau Medical Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting DRTS on Form N-PORT; together they hold 0.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
DS Dunham Small Cap Growth Fund Dunham Funds	$845K	71.7K	0.08%	1.06%	July 31, 2026

Dunham Small Cap Growth Fund

Dunham Funds

Position value

$845K

% of company

0.08%

% of the fund

1.06%

As of

July 31, 2026

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
OP Oramed Pharmaceuticals Inc. 5%+ holder 13D · 20.0%	14.1M	16.03%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company16.030% Disclosed stake13D · 20.0% View the 13D/G filing →

Oramed Pharmaceuticals Inc.

5%+ holder13D · 20.0%

14.1M

% of company

16.03%

Change vs last qtr

—

Held since

—

Comments